Companies: 10,795·Total market cap: $144.5T
Cytek Biosciences, Inc.

Cytek Biosciences, Inc.

CTKBNASDAQHealthcare● Active
$4.05
$-0.04(-1.05%)
Market Cap$522640050
P/E Ratio
52W High$6.18
52W Low$2.9

Cytek Biosciences, Inc.(CTKB)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

ctkb · 股价预测 · 5 位分析师(近3月)· FMP

分析师评级与共识

基于过去 3 个月内 5 位华尔街分析师

SellBuy

Buy

5 位分析师

共识

评级分布

Strong Buy
0
Buy
3
Hold
1
Sell
1
Strong Sell
0
合计: 5 · 买入占比: 60.0%

12 个月目标价

High

$5.50

Consensus

$5.13

+26.8% upside

Low

$4.75

Median: $5.125 · Last Close: $4.05

Cytek Biosciences, Inc.(CTKB)的分析师共识为 Buy,基于过去 3 个月内 5 位华尔街分析师的评级。CTKB 的 12 个月平均目标价为 $5.13,相对当前价 $4.05 代表 +26.8% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

Historical priceConsensus $5 (26.8%)

Consensus Target

$5.13

26.8% upside

High Target

$5.5

35.9%

Low Target

$4.75

17.4%

Current Price

$4.05

as of today

Based on analyst price targets, the CTKB stock price prediction for the next 12 months ranges from $4.75 to $5.5. The consensus CTKB price forecast of $5.13 implies 26.8% upside from the current price of $4.05.

短期股价预测

预测引擎就绪后将提供短期股价预测。

长期股价预测

预测引擎就绪后将提供长期股价预测。

基于技术分析的股价预测

预测引擎就绪后将提供技术分析。

最新分析师评级与调整

Filter:

Wall Street analysts have recently issued updated ratings on Cytek Biosciences, Inc. (CTKB) stock. Of the recent 0 rating actions, 0 were upgrades and 0 were downgrades. 5 analysts currently cover CTKB.

分析师推荐趋势

CTKB analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

Revenue Next Year

EPS This Year

EPS Next Year

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CTKB EPS of $ for the current fiscal year, based on estimates from 0 analysts. The CTKB revenue forecast is for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

CTKB 股价预测由两类独立数据源支撑:来自 5 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。CTKB 的共识目标价为 $5.13(+26.8% 上行空间),分析师共识为 Buy。

Cytek Biosciences, Inc. 在 NASDAQ 上市,代码 CTKB。CTKB 在 2027 年的整体展望偏积极,在覆盖分析师中约 60% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

CTKB 预测 · 8 个问题

根据 5 位华尔街分析师,CTKB 的 12 个月平均目标价为 $5.13,最高 $5.50、最低 $4.75。若有图表,中位目标价可在上方查看。相对当前价 $4.05,隐含约 +26.8% 的上行空间。

CTKB 目标价CTKB 分析师目标价CTKB 12个月目标价目标价 CTKB

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.